Cargando…

488. Comparison of Demographics and Clinical Characteristics of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease

BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is an illness associated with recent SARS-CoV-2 infection or exposure. Kawasaki disease (KD), a vasculitis with an unknown etiology, has overlapping clinical presentation with MIS-C, making it difficult to clinicians for distinguish b...

Descripción completa

Detalles Bibliográficos
Autores principales: Talj, Rana, Yanis, Ahmad, Rankin, Danielle A, Starnes, Joseph R, Starnes, Lauren S, Clark, Daniel E, Parra, David, Patrick, Anna E, Katz, Sophie E, Halasa, Natasha B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644089/
http://dx.doi.org/10.1093/ofid/ofab466.687
_version_ 1784610005455994880
author Talj, Rana
Yanis, Ahmad
Rankin, Danielle A
Starnes, Joseph R
Starnes, Lauren S
Clark, Daniel E
Parra, David
Patrick, Anna E
Katz, Sophie E
Halasa, Natasha B
Halasa, Natasha B
author_facet Talj, Rana
Yanis, Ahmad
Rankin, Danielle A
Starnes, Joseph R
Starnes, Lauren S
Clark, Daniel E
Parra, David
Patrick, Anna E
Katz, Sophie E
Halasa, Natasha B
Halasa, Natasha B
author_sort Talj, Rana
collection PubMed
description BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is an illness associated with recent SARS-CoV-2 infection or exposure. Kawasaki disease (KD), a vasculitis with an unknown etiology, has overlapping clinical presentation with MIS-C, making it difficult to clinicians for distinguish between them. Therefore, we aimed to compare demographic, laboratory, and clinical characteristics between MIS-C and KD in hospitalized children in Nashville, TN. METHODS: We conducted a single-center retrospective chart review for hospitalized children under 18 years who met American Heart Association criteria for KD and were treated with intravenous immunoglobulin from May 2000 to December 2019, and children meeting the CDC criteria for MIS-C from July 2020 to May 2021. Data abstraction for patients’ demographics, clinical presentation, laboratory values and imaging results was performed. Pearson’s chi-squared test for categorical variables and Wilcoxon rank sum test for continuous variables, with alpha=5%, were used to compare groups. RESULTS: A total of 603 KD and 52 MIS-C hospitalized patients were included. Children with MIS-C were older than those with KD. A higher frequency of male sex was noted in both groups, with no significant differences in race and ethnicity (Table). MIS-C children frequently presented with symptoms similar to KD (63.5% rash, 55.8% conjunctivitis, 28.9% mucous membrane changes); however, only one MIS-C patient met criteria for complete KD (Figure). Both MIS-C and KD children presented with elevated CRP and ESR, but the median value of CRP in MIS-C children was significantly higher (Table). In addition, white cell count was lower in MIS-C children, which is primarily driven by the lower absolute lymphocyte count in this group (0.9 vs 2.7, p< 0.001), and echocardiography was more likely to be abnormal at presentation compared to KD (Table). Table. Comparison of Sociodemographic, Clinical, and Laboratory Characteristics among Children with Kawasaki Disease and Multisystem Inflammatory Syndrome in Nashville [Image: see text] Figure. Comparison of Kawasaki Criteria Between Children with Multisystem Inflammatory Syndrome and Kawasaki Disease [Image: see text] CONCLUSION: MIS-C and KD present similarly in children; however, age, laboratory and echocardiography findings can help differentiate between them. Different laboratory values suggest different pathophysiology and inflammatory mediators behind these two illnesses, warranting further research. DISCLOSURES: Natasha B. Halasa, MD, MPH, Genentech (Other Financial or Material Support, I receive an honorarium for lectures - it’s a education grant, supported by genetech)Quidel (Grant/Research Support, Other Financial or Material Support, Donation of supplies/kits)Sanofi (Grant/Research Support, Other Financial or Material Support, HAI/NAI testing) Natasha B. Halasa, MD, MPH, Genentech (Individual(s) Involved: Self): I receive an honorarium for lectures - it’s a education grant, supported by genetech, Other Financial or Material Support, Other Financial or Material Support; Sanofi (Individual(s) Involved: Self): Grant/Research Support, Research Grant or Support
format Online
Article
Text
id pubmed-8644089
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86440892021-12-06 488. Comparison of Demographics and Clinical Characteristics of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease Talj, Rana Yanis, Ahmad Rankin, Danielle A Starnes, Joseph R Starnes, Lauren S Clark, Daniel E Parra, David Patrick, Anna E Katz, Sophie E Halasa, Natasha B Halasa, Natasha B Open Forum Infect Dis Poster Abstracts BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is an illness associated with recent SARS-CoV-2 infection or exposure. Kawasaki disease (KD), a vasculitis with an unknown etiology, has overlapping clinical presentation with MIS-C, making it difficult to clinicians for distinguish between them. Therefore, we aimed to compare demographic, laboratory, and clinical characteristics between MIS-C and KD in hospitalized children in Nashville, TN. METHODS: We conducted a single-center retrospective chart review for hospitalized children under 18 years who met American Heart Association criteria for KD and were treated with intravenous immunoglobulin from May 2000 to December 2019, and children meeting the CDC criteria for MIS-C from July 2020 to May 2021. Data abstraction for patients’ demographics, clinical presentation, laboratory values and imaging results was performed. Pearson’s chi-squared test for categorical variables and Wilcoxon rank sum test for continuous variables, with alpha=5%, were used to compare groups. RESULTS: A total of 603 KD and 52 MIS-C hospitalized patients were included. Children with MIS-C were older than those with KD. A higher frequency of male sex was noted in both groups, with no significant differences in race and ethnicity (Table). MIS-C children frequently presented with symptoms similar to KD (63.5% rash, 55.8% conjunctivitis, 28.9% mucous membrane changes); however, only one MIS-C patient met criteria for complete KD (Figure). Both MIS-C and KD children presented with elevated CRP and ESR, but the median value of CRP in MIS-C children was significantly higher (Table). In addition, white cell count was lower in MIS-C children, which is primarily driven by the lower absolute lymphocyte count in this group (0.9 vs 2.7, p< 0.001), and echocardiography was more likely to be abnormal at presentation compared to KD (Table). Table. Comparison of Sociodemographic, Clinical, and Laboratory Characteristics among Children with Kawasaki Disease and Multisystem Inflammatory Syndrome in Nashville [Image: see text] Figure. Comparison of Kawasaki Criteria Between Children with Multisystem Inflammatory Syndrome and Kawasaki Disease [Image: see text] CONCLUSION: MIS-C and KD present similarly in children; however, age, laboratory and echocardiography findings can help differentiate between them. Different laboratory values suggest different pathophysiology and inflammatory mediators behind these two illnesses, warranting further research. DISCLOSURES: Natasha B. Halasa, MD, MPH, Genentech (Other Financial or Material Support, I receive an honorarium for lectures - it’s a education grant, supported by genetech)Quidel (Grant/Research Support, Other Financial or Material Support, Donation of supplies/kits)Sanofi (Grant/Research Support, Other Financial or Material Support, HAI/NAI testing) Natasha B. Halasa, MD, MPH, Genentech (Individual(s) Involved: Self): I receive an honorarium for lectures - it’s a education grant, supported by genetech, Other Financial or Material Support, Other Financial or Material Support; Sanofi (Individual(s) Involved: Self): Grant/Research Support, Research Grant or Support Oxford University Press 2021-12-04 /pmc/articles/PMC8644089/ http://dx.doi.org/10.1093/ofid/ofab466.687 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Talj, Rana
Yanis, Ahmad
Rankin, Danielle A
Starnes, Joseph R
Starnes, Lauren S
Clark, Daniel E
Parra, David
Patrick, Anna E
Katz, Sophie E
Halasa, Natasha B
Halasa, Natasha B
488. Comparison of Demographics and Clinical Characteristics of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease
title 488. Comparison of Demographics and Clinical Characteristics of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease
title_full 488. Comparison of Demographics and Clinical Characteristics of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease
title_fullStr 488. Comparison of Demographics and Clinical Characteristics of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease
title_full_unstemmed 488. Comparison of Demographics and Clinical Characteristics of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease
title_short 488. Comparison of Demographics and Clinical Characteristics of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease
title_sort 488. comparison of demographics and clinical characteristics of multisystem inflammatory syndrome in children and kawasaki disease
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644089/
http://dx.doi.org/10.1093/ofid/ofab466.687
work_keys_str_mv AT taljrana 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT yanisahmad 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT rankindaniellea 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT starnesjosephr 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT starneslaurens 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT clarkdaniele 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT parradavid 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT patrickannae 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT katzsophiee 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT halasanatashab 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease
AT halasanatashab 488comparisonofdemographicsandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenandkawasakidisease